Huntsman Cancer Hospital

Salt Lake City, Utah 84132

1 studies enrolling now · 21 studies all time

What they study most

Acromegaly, Acute Myeloid Leukemia, Advanced Prostate Cancer, Advanced Solid Tumors, Breast Cancer, CD33 Positive Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myeloid Leukemia, Colorectal Cancer, Eosinophilic Esophagitis, Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma

Studies at this site

• An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 — Enrolling by invitation
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy — Completed
• A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis — Completed
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed
• A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients — Completed
• Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer — Completed
• Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States — Completed
• Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer — Completed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
• Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer — Completed
• A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia — Completed
• Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly — Status unconfirmed
• Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day — Stopped early
• A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors — Completed
• Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
• PF-06671008 Dose Escalation Study in Advanced Solid Tumors — Stopped early
• Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy — NO_LONGER_AVAILABLE
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery — Completed
• An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 — Completed